FAF-Drugs: Free ADME/tox filtering of compound collections

Nucleic Acids Research

Volumn 34, Issue WEB. SERV. ISS., 2006, Pages

  Miteva, Maria A ^a   Violas, Stephanie ^a   Montes, Matthieu ^a   Gomez, David ^a   Tuffery, Pierre ^a   Villoutreix, Bruno O ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,4 TRICHLOROBENZENE; CINEOLE; PHENOBARBITAL; TRIETHYL PHOSPHATE; UNCLASSIFIED DRUG; DRUG;

ARTICLE; COMPUTER ANALYSIS; COMPUTER INTERFACE; COMPUTER MODEL; COMPUTER PROGRAM; CONTROLLED STUDY; DATA BASE; DRUG ABSORPTION; DRUG DISTRIBUTION; DRUG EXCRETION; DRUG INFORMATION; DRUG METABOLISM; DRUG RESEARCH; DRUG SAFETY; DRUG STRUCTURE; FILTRATION; INFORMATION RETRIEVAL; INTERNET; MOLECULAR WEIGHT; ONLINE SYSTEM; PRIORITY JOURNAL; SCIENTIST; SURFACE PROPERTY; CHEMISTRY; DRUG DESIGN; DRUG TOXICITY; PHARMACOKINETICS;

DRUG DESIGN; DRUG TOXICITY; INTERNET; PHARMACEUTICAL PREPARATIONS; PHARMACOKINETICS; SOFTWARE; USER-COMPUTER INTERFACE;

EID: 33747851729     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkl065     Document Type: Article

References (50)

1. Shoichet,B.K. (2004) Virtual screening of chemical libraries. Nature, 432, 862-865.
2. Lyne,P.D. (2002) Structure-based virtual screening: an overview. Drug Discov. Today, 7, 1047-1055.
3. Bleicher,K.H., Bohm,H.J., Muller,K. and Alanine,A.I. (2003) Hit and lead generation: beyond high-throughput screening. Nature Rev. Drug Discov., 2, 369-378.
4. Jennings,A. and Tennant,M. (2005) Discovery strategies in a BioPharmaceutical startup: maximising your chances of success using computational filters. Curr. Pharm. Des., 11, 335-344.
5. McConkey,B.J., Sobolev,V. and Edelman,M. (2002) The performance of current methods in ligand-protein docking. Current Science, 83, 845-856.
6. Lengauer,T., Lemmen,C., Rarey,M. and Zimmermann,M. (2004) Novel technologies for virtual screening. Drug Discov. Today, 9, 27-34.
7. Kitchen,D.B., Decornez,H., Furr,J.R. and Bajorath,J. (2004) Docking and scoring in virtual screening for drug discovery: methods and applications. Nature Rev. Drug Discov., 3, 935-949.
8. Oprea,T.I. and Matter,H. (2004) Integrating virtual screening in lead discovery. Curr. Opin. Chem. Biol., 8, 349-358.
9. Jain,A.N. (2004) Virtual screening in lead discovery and optimization. Curr. Opin. Drug Discov. Devel., 7, 396-403.
10. Fradera,X. and Mestres,J. (2004) Guided docking approaches to structure-based design and screening. Curr. Top.Med. Chem., 4, 687-700.
11. Stahura,F.L. and Bajorath,J. (2005) New methodologies for ligand-based virtual screening. Curr. Pharm. Des., 11, 1189-1202.
12. Congreve,M., Murray,C.W. and Blundell,T.L. (2005) Structural biology and drug discovery. Drug. Discov. Today, 10, 895-907.
13. Hardy,L.W. and Malikayil,A. (2003) The impact of structure-guided drug design on clinical agents. Curr. Drug. Discov., 15, 15-20.
14. Abagyan,R. and Totrov,M. (2001) High-throughput docking for lead generation. Curr. Opin. Chem. Biol., 5, 375-382.
15. Alvarez,J.C. (2004) High-throughput docking as a source of novel drug leads. Curr. Opin. Chem. Biol., 8, 365-370.
16. Schneider,G. and Bohm,H.J. (2002) Virtual screening and fast automated docking methods. Drug. Discov. Today, 7, 64-70.
17. Kassel,D.B. (2004) Applications of high-throughput ADME in drug discovery. Curr. Opin. Chem. Biol., 8, 339-345.
18. Muegge,I. (2003) Selection criteria for drug-like compounds. Med. Res. Rev., 23, 302-321.
19. Hou,T. and Xu,X. (2004) Recent development and application of virtual screening in drug discovery: an overview. Curr. Pharm. Des., 10, 1011-1033.
20. Beresford,A.P., Segall,M. and Tarbit,M.H. (2004) In silico prediction of ADME properties: are we making progress? Curr. Opin. Drug Discov. Devel., 7, 36-42.
21. Lombardo,F., Gifford,E. and Shalaeva,M.Y. (2003) In silico ADME prediction: data, models, facts and myths. Mini. Rev. Med. Chem., 3, 861-875.
22. Gasteiger,J. (2003) Physicochemical effects in the representation of molecular structures for drug designing. Mini. Rev. Med. Chem., 3, 789-796.
23. Martin,Y.C. (2005) A bioavailability score. J. Med. Chem., 48, 3164-3170.
24. Rishton,G.M. (2003) Nonleadlikeness and leadlikeness in biochemical screening. Drug Discov. Today, 8, 86-96.
25. Lipinski,C.A., Lombardo,F., Dominy,B.W. and Feeney,P.J. (2001) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev., 46, 3-26.
26. Li,A.P. (2001) Screening for human ADME/Tox drug properties in drug discovery. Drug Discov. Today, 6, 357-366.
27. Roche,O. and Guba,W. (2005) Computational chemistry as an integral component of lead generation. Mini. Rev. Med. Chem., 5, 677-683.
28. Vermeulen,N.P. (2003) Prediction of drug metabolism: the case of cytochrome P450 2D6. Curr. Top. Med. Chem., 3, 1227-1239.
29. Veber,D.F., Johnson,S.R., Cheng,H.Y., Smith,B.R., Ward,K.W. and Kopple,K.D. (2002) Molecular properties that influence the oral bioavailability of drug candidates. J. Med. Chem., 45, 2615-2623.
30. Ertl,P., Rohde,B. and Selzer,P. (2000) Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties. J. Med. Chem., 43, 3714-3717.
31. Nassar,A.E., Kamel,A.M. and Clarimont,C. (2004) Improving the decision-making process in structural modification of drug candidates: reducing toxicity. Drug Discov. Today, 9, 1055-1064.
32. Oprea,T.D. (2002) Virtual screening in lead discovery. Molecules, 7, 51-62.
33. Kubinyi,H. (2003) Drug research: myths, hype and reality. Nature Rev. Drug Discov., 2, 665-668.
34. Yu,H. and Adedoyin,A. (2003)ADME-Toxin drug discovery: integration of experimental and computational technologies. Drug Discov. Today, 8, 852-861.
35. van de Waterbeemd,H. and Gifford,E. (2003) ADMET in silico modelling: towards prediction paradise? Nature Rev. Drug Discov., 2, 192-204.
36. Baurin,N., Baker,R., Richardson,C., Chen,I., Foloppe,N., Potter,A., Jordan,A., Roughley,S., Parratt,M., Greaney,P. et al. (2004) Drug-like annotation and duplicate analysis of a 23 - supplier chemical database totalling 2.7 million compounds. J. Chem. Inf. Comput. Sci., 44, 643-651.
37. Irwin,J.J. and Shoichet,B.K. (2005) ZINC-a free database of commercially available compounds for virtual screening. J. Chem. Inf. Model., 45, 177-182.
38. Wang,R., Gao,Y. and Lai,L. (2000) Calculating partition coefficient by atom-additive method. Perspectives in Drug Discovery and Design, 19, 47-66.
39. Frimurer,T.M., Bywater,R., Naerum,L., Lauristen,L.N. and Brunak,S. (2000) Improving the odds in discriminating drug-like from non-drug-like compounds. J. Chem. Inf. Comput. Sci., 40, 1315-1324.
40. Walters,W.P., Stahl,M.T. and Murcko,M.A. (1998) Virtual screening. Drug Discov. Today, 3, 160-178.
41. Baurin,N., Aboul-Ela,F., Barril,X., Davis,B., Drysdale,M., Dymock,B., Finch,H., Fromont,C., Richardson,C., Simmonite,H. et al. (2004) Design and characterization of libraries of molecular fragments for use in NMR screening against protein targets. J. Chem. Inf. Comput. Sci., 44, 2157-2166.
42. Tetko,I.V. and Tanchuk,V.Y. (2002) Application of associative neural networks for prediction of lipophilicity in ALOGPS 2.1 program. J. Chem. Inf. Comput. Sci., 42, 1136-1145.
43. Brady,G.P. Jr. and Stouten,P.F. (2000) Fast prediction and visualization of protein binding pockets with PASS. J. Comput. Aided Mol. Des. 14, 383-401.
44. Strausberg,R.L. and Schreiger,S.L. (2003) From knowing to controlling: a path from genomics to drugs using small molecule probes. Science, 294-295.
45. Kanehisa,M. (1997) Linking databases and organisms. Trends Biochem. Sci., 22, 442-444.
46. Grotthuss,v.M., Pas,J. and Rychlewski,L. (2003) Ligand-Info, searching for similar small compounds using index profiles. Bioinformatics, 19, 1041-1042.
47. Girke,T., Cheng,L.C. and Raikhel,N. (2005) ChemMine. A compound mining database for chemical genomics. Plant Physiol., 138, 573-577.
48. Chen,X., Lin,Y. and Gilson,M.K. (2002) The binding database. Biopolymers Nucleic Acid. Sci., 61, 127-142.
49. Wang,R., Fang,X., Lu,Y., Yang,C.Y. and Wang,S. (2005) The PDBbind database: methodologies and updates. J. Med. Chem., 48, 4111-4119.
50. Zhang,J., Aizawa,M., Amari,S., Iwasawa,Y., Nakano,T. and Nakata,K. (2004) Development of KiBank, a database supporting structure-based drug design. Comput. Biol. Chem., 28, 401-407.